Hygieia Biological Laboratories
Hygieia Biological Laboratories is a privately held biotechnology company based in Woodland, California, with a focus on research, development, and manufacturing of innovative veterinary and human vaccines and pharmaceuticals. With expertise in vaccines for dairy, poultry, cattle, small ruminants, and aquaculture, the company is dedicated to solving disease problems using traditional, modern, and novel technologies. Established in 1991, Hygieia employs around 70 people and occupies 100,000 square feet of laboratory and related facilities. The company has a history of firsts in vaccine development, including the only manufacturer of vaccines against venom and the first to produce vaccines for bovine mastitis caused by Streptococcus uberis and epizootic bovine abortion.
Industries
Nr. of Employees
small (1-50)
Hygieia Biological Laboratories
P.O. Box 8300, Woodland, California 95776 USA
Products
Streptococcus uberis bacterin (dairy vaccine)
Strain-specific inactivated vaccine targeting Streptococcus uberis for dairy cattle mastitis prevention; supplied with administration and storage guidance.
Escherichia coli bacterin (dairy/companion indications)
Inactivated E. coli bacterin for prevention of E. coli-associated disease in target animal populations.
Epizootic bovine abortion vaccine (beef)
Vaccine product addressing epizootic bovine abortion in beef cattle.
Avian live-virus vaccines (poultry)
Live-virus vaccine formulations for avian pathogens including avian encephalomyelitis, fowl pox, pigeon pox and combinations with other avian viruses.
Hemorrhagic enteritis vaccine (poultry)
Vaccine addressing hemorrhagic enteritis in avian species (live virus formulation referenced).
Semen extender (avian use)
Semen extender product for avian reproductive management.
Streptococcus uberis bacterin (dairy vaccine)
Strain-specific inactivated vaccine targeting Streptococcus uberis for dairy cattle mastitis prevention; supplied with administration and storage guidance.
Escherichia coli bacterin (dairy/companion indications)
Inactivated E. coli bacterin for prevention of E. coli-associated disease in target animal populations.
Epizootic bovine abortion vaccine (beef)
Vaccine product addressing epizootic bovine abortion in beef cattle.
Avian live-virus vaccines (poultry)
Live-virus vaccine formulations for avian pathogens including avian encephalomyelitis, fowl pox, pigeon pox and combinations with other avian viruses.
Hemorrhagic enteritis vaccine (poultry)
Vaccine addressing hemorrhagic enteritis in avian species (live virus formulation referenced).
Semen extender (avian use)
Semen extender product for avian reproductive management.
Services
Custom development and manufacture of inactivated autogenous bacterins and viral vaccines from strains isolated at a client facility; work conducted in collaboration with veterinarians and animal owners, with options for variable packaging and no minimum order.
Provision of product brochures, administration instructions, storage/handling guidance, and FAQ support for vaccine products.
Custom development and manufacture of inactivated autogenous bacterins and viral vaccines from strains isolated at a client facility; work conducted in collaboration with veterinarians and animal owners, with options for variable packaging and no minimum order.
Provision of product brochures, administration instructions, storage/handling guidance, and FAQ support for vaccine products.
Expertise Areas
- Vaccine development for veterinary species
- Autogenous (strain-specific) vaccine production
- Live virus and inactivated bacterin vaccine manufacturing
- Pathogen isolation and strain selection
Key Technologies
- Inactivated bacterin vaccine production
- Live-virus vaccine production
- Pathogen isolation and strain-specific formulation
- Vaccine formulation and safety process development
News & Updates
First company to manufacture a vaccine against bovine mastitis caused by Streptococcus uberis
Hygieia was the first company in the world to produce a vaccine targeting bovine mastitis caused by Streptococcus uberis.
First company to manufacture a commercial vaccine against epizootic bovine abortion
Hygieia pioneered the development of a vaccine for epizootic bovine abortion, a significant advancement in veterinary medicine.
First company to manufacture a vaccine against bovine mastitis caused by Streptococcus uberis
Hygieia was the first company in the world to produce a vaccine targeting bovine mastitis caused by Streptococcus uberis.
First company to manufacture a commercial vaccine against epizootic bovine abortion
Hygieia pioneered the development of a vaccine for epizootic bovine abortion, a significant advancement in veterinary medicine.